These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1579 related articles for article (PubMed ID: 16318813)
1. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence]. Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813 [TBL] [Abstract][Full Text] [Related]
2. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. Pan CW; Shen ZJ; Ding GQ J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576 [TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer]. Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455 [TBL] [Abstract][Full Text] [Related]
4. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2]. Wen R; Zhou G; Xie S; Lian B; Sun X; Chen J Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381 [TBL] [Abstract][Full Text] [Related]
5. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related]
6. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [TBL] [Abstract][Full Text] [Related]
8. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. Andius P; Holmäng S BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147 [TBL] [Abstract][Full Text] [Related]
12. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y; Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of postoperative recurrence of human bladder carcinoma by intravesical instillation of immunotoxin, a clinical study]. Tong M; Yu LZ; Ding Y; Liu LB; Pan BN; Na YQ Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):201-3. PubMed ID: 12812661 [TBL] [Abstract][Full Text] [Related]
15. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer. Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743 [TBL] [Abstract][Full Text] [Related]
17. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence]. Irie A; Lee KE; Kadowaki K; Sawamura M Hinyokika Kiyo; 1994 Oct; 40(10):873-7. PubMed ID: 7992700 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment. Okamura T; Akita H; Imura M; Kaneko T; Mizuno K; Tozawa K; Kohri K Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199 [TBL] [Abstract][Full Text] [Related]
19. Immunoprophylaxis of superficial bladder cancer: a prospective and randomized comparison of oral versus intravesical Bacillus Calmette-Guerin. Netto Júnior NR; Levi d'Ancona CA; Claro JF; Ilari O Arch Esp Urol; 1991 Oct; 44(8):1025-8. PubMed ID: 1796850 [TBL] [Abstract][Full Text] [Related]
20. [Enhancement of bacillus Calmette-Guerin attachment to the bladder wall: experimental study]. Shen Z; Ding G; Chen Z Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):951-3. PubMed ID: 16201181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]